Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...